TEMPO LEAD
RESOURCES
NEWS
CONTACT
More
Tempo® Temporary Pacing Lead Acquired by Merit Medical Systems, Inc.
Experience with BioTrace Medical’s Tempo Temporary Pacing Lead in Management of Bradyarrhythmia Presented at the American Heart Association’s Scientific Sessions 2021
Experience with BioTrace Medical’s Tempo Temporary Pacing Lead in Mitral Valve Surgeries Presented at Society of Cardiovascular Anesthesiologists’ 43rd Annual Meeting
BioTrace Medical Announces Key Events Featuring Tempo Temporary Pacing Lead at TCT 2019; Multi-center U.S. study demonstrating safety and efficacy of the Tempo Lead published in Catheterization and Cardiovascular Interventions
BioTrace Medical Announces Key Events Featuring Tempo Temporary Pacing Lead at TVT 2019: New TAVR Standard of Care Technology to be Featured in Lunch Symposium, Live Cases, and Podium Presentation
BioTrace Medical’s Tempo Lead Obtains CE Mark for Safe and Secure Temporary Intracardiac Pacing
BioTrace Medical Announces Key Events Featuring Tempo® Lead at TCT 2018: Company’s Tempo Temporary Pacing Lead Has Been Used in More Than 1,500 Procedures with No Perforations
BioTrace Medical Announces Key Events Featuring Tempo® Lead at TVT 2018: Presentations Will Highlight Use of Tempo Lead as New Standard of Care in Temporary Pacing That Results in Earlier Ambulation and Reduced Length of Stay
BioTrace Medical Announces Publication of Positive Data from First-In-Human Clinical Study in Journal of Invasive Cardiology: First-In- Human Study Demonstrates Safety and Effectiveness of Tempo® Temporary Pacing Lead, Confirmed Recently in Expanded U.S. Retrospective Study
BioTrace Medical’s Tempo® Lead featured in Cardiac Interventions Today March/April Worldwide TAVR Trends edition: "Rethinking The Temporary Pacing Lead"
Safety and Effectiveness of BioTrace Medical’s Tempo® Lead Further Demonstrated in Multi-Center Analysis of More Than 200 Cardiac Procedures
BioTrace Medical Announces Key Events Featuring Tempo® Temporary Pacing Lead at TCT 2017
Cardiac Interventions Today July/Aug TVT 2017 Convention Coverage: "Real-World Data Presented for BioTrace Medical's Tempo® Lead in TAVR Procedures"
BioTrace Medical Receives ISO 13485 Quality Management System Certification
Cardiac Interventions Today Showcases the Tempo® Temporary Pacing Lead in Most Recent "Innovations" Feature
BioTrace Medical’s Tempo® Lead Shows Stability and Safety in Real-World Performance Consistent with Clinical Study Outcomes In TVT 2017 Presentation
BioTrace Medical Announces Key Activities at TVT 2017: Tempo® Temporary Pacing Lead to be featured in New Technology Forum and Live Cases
Tempo® Temporary Pacing Lead First-In-Human Clinical Study Results Presented at 2017 Heart Rhythm Society Meeting
The MedTech Strategist: Serving a Growing TAVR Market With Safer Temporary Pacing
Medical Product Manufacturing News: Could BioTrace Set A New ‘Tempo’ for Temporary Pacing?
BioTrace Medical Announces Positive Data From Clinical Study of Innovative Temporary Pacing Technology
BioTrace Medical Announces FDA Clearance of Innovative Temporary Pacing Technology for Transcatheter Aortic Valve Procedures and Other Cardiovascular Applications
Innovations in Temporary Pacing
TAVR experts discuss their use of the Tempo Lead to avoid complications, reduce costs, and ease ICU capacity constraints
